www.fdanews.com/articles/142902-ema-grants-orphan-drug-status-to-novabiotics-lynovex

EMA Grants Orphan Drug Status to NovaBiotics Lynovex

January 4, 2012

UK-based biotechnology company, NovaBiotics’ Lynovex has been granted orphan drug designation in Europe by the Committee on Orphan EMA.
Pharmaceutical Business Review